| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Serina Therapeutics, Inc. (SER) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. SER is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 230.1K | $359.0K | - | |
| Dir | 126.9K | $198.0K | - | |
| Dir | 92.0K | $143.5K | - | |
| VP | 69.0K | $107.6K | - | |
| Dir | 10.0K | $15.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2019 | Juvenescence Ltd | 10% Owner | Buy | 19,000 | $0.00 | - | +0.1% | |
| Dec 10, 2018 | West Michael D | Chief Executive Officer | Buy | 4,000 | $3.86 | $15,442.80 | +34.9% |